S&P 500   4,975.51
DOW   38,563.80
QQQ   427.32
Higher VIX just made Realty Income’s 6% dividend better
Better Than Oil Stocks (Ad)
Super Micro Computer: Overbought, undervalued or mispriced?
Booking stock is the discounted growth story in travel stocks
Better Than Oil Stocks (Ad)
3 E-VTOL stocks: Which ones can fly higher in 2024?
Capital One's bid for Discover carries expectation that Americans won't slow credit card use
66,000% upside on tiny biotech? (Ad)
Walmart’s uptrend is intact; buy it when it dips
XPeng stock just got a target boost, analysts say it could double
S&P 500   4,975.51
DOW   38,563.80
QQQ   427.32
Higher VIX just made Realty Income’s 6% dividend better
Better Than Oil Stocks (Ad)
Super Micro Computer: Overbought, undervalued or mispriced?
Booking stock is the discounted growth story in travel stocks
Better Than Oil Stocks (Ad)
3 E-VTOL stocks: Which ones can fly higher in 2024?
Capital One's bid for Discover carries expectation that Americans won't slow credit card use
66,000% upside on tiny biotech? (Ad)
Walmart’s uptrend is intact; buy it when it dips
XPeng stock just got a target boost, analysts say it could double
S&P 500   4,975.51
DOW   38,563.80
QQQ   427.32
Higher VIX just made Realty Income’s 6% dividend better
Better Than Oil Stocks (Ad)
Super Micro Computer: Overbought, undervalued or mispriced?
Booking stock is the discounted growth story in travel stocks
Better Than Oil Stocks (Ad)
3 E-VTOL stocks: Which ones can fly higher in 2024?
Capital One's bid for Discover carries expectation that Americans won't slow credit card use
66,000% upside on tiny biotech? (Ad)
Walmart’s uptrend is intact; buy it when it dips
XPeng stock just got a target boost, analysts say it could double
S&P 500   4,975.51
DOW   38,563.80
QQQ   427.32
Higher VIX just made Realty Income’s 6% dividend better
Better Than Oil Stocks (Ad)
Super Micro Computer: Overbought, undervalued or mispriced?
Booking stock is the discounted growth story in travel stocks
Better Than Oil Stocks (Ad)
3 E-VTOL stocks: Which ones can fly higher in 2024?
Capital One's bid for Discover carries expectation that Americans won't slow credit card use
66,000% upside on tiny biotech? (Ad)
Walmart’s uptrend is intact; buy it when it dips
XPeng stock just got a target boost, analysts say it could double

Olema Pharmaceuticals (OLMA) Short Interest Ratio & Short Volume

$14.34
-0.65 (-4.34%)
(As of 02/20/2024 ET)

Olema Pharmaceuticals Short Interest Data

Current Short Volume
6,710,000 shares
Previous Short Volume
7,080,000 shares
Change Vs. Previous Month
-5.23%
Dollar Volume Sold Short
$87.50 million
Short Interest Ratio / Days to Cover
7.5
Last Record Date
January 31, 2024
Outstanding Shares
55,100,000 shares
Percentage of Shares Shorted
12.18%
Today's Trading Volume
840,276 shares
Average Trading Volume
688,803 shares
Today's Volume Vs. Average
122%
cover of A Guide to High-Short-Interest Stocks and How to Trade Them ebook
Short Selling Olema Pharmaceuticals ?

Sign up to receive the latest short interest report for Olema Pharmaceuticals and its competitors with MarketBeat's FREE newsletter.

Skip Charts & View Short Interest History

OLMA Short Interest Over Time

OLMA Days to Cover Over Time

OLMA Percentage of Float Shorted Over Time


Olema Pharmaceuticals Short Interest History

Report DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date
1/31/20246,710,000 shares $87.50 million -5.2%N/A7.5 $13.04
1/15/20247,080,000 shares $82.13 million +0.7%N/A8.3 $11.60
12/31/20237,030,000 shares $98.63 million +5.7%N/A8.5 $14.03
12/15/20236,650,000 shares $81.13 million +27.6%N/A8.5 $12.20
11/30/20235,210,000 shares $72.68 million +88.8%N/A8.1 $13.95
11/15/20232,760,000 shares $46.42 million No ChangeN/A6.4 $16.82
10/31/20232,760,000 shares $36.68 million +26.0%7.3%7.9 $13.29
10/15/20232,190,000 shares $27.66 million +10.6%5.8%7.6 $12.63
9/30/20231,980,000 shares $24.45 million +12.5%5.4%7.1 $12.35
9/15/20231,760,000 shares $22.69 million +10.7%4.8%5.9 $12.89
8/31/20231,590,000 shares $16.14 million -9.7%4.4%4.1 $10.15
8/15/20231,760,000 shares $19.03 million -4.4%5.0%4.8 $10.81
7/31/20231,840,000 shares $15.92 million -4.7%5.3%5.1 $8.65
7/15/20231,930,000 shares $15.81 million +5.5%5.6%5.4 $8.19
6/30/20231,830,000 shares $16.52 million +55.1%5.3%5 $9.03
6/15/20231,180,000 shares $10.71 million +14.6%3.4%3.7 $9.08
5/31/20231,030,000 shares $5.33 million No Change3.0%5.2 $5.17
5/15/20231,030,000 shares $6.89 million +1.0%3.0%6.2 $6.69
4/30/20231,020,000 shares $4.89 million -6.4%3.0%6 $4.79
4/15/20231,090,000 shares $3.99 million -4.4%3.2%6.5 $3.66
3/31/20231,140,000 shares $3.96 million +3.6%3.3%6.3 $3.47
3/15/20231,100,000 shares $4.38 million -1.8%3.2%7.5 $3.98
2/28/20231,120,000 shares $4.59 million -21.1%3.3%7.5 $4.10
2/15/20231,420,000 shares $6.38 million No Change4.1%9.1 $4.49
1/31/20231,420,000 shares $6.86 million -7.2%4.1%8.7 $4.83
1/15/20231,530,000 shares $6.35 million +1.3%4.5%10.3 $4.15
12/30/20221,510,000 shares $3.70 million -5.6%4.4%12.5 $2.45
12/15/20221,600,000 shares $3.92 million +1.3%4.7%12.3 $2.45
11/30/20221,580,000 shares $4.53 million -3.1%4.6%10.7 $2.87
11/15/20221,630,000 shares $5.22 million +4.5%4.7%10.2 $3.20
10/31/20221,560,000 shares $5.87 million +3.3%4.5%8 $3.76
10/15/20221,510,000 shares $4.32 million -3.2%4.4%7.3 $2.86
9/30/20221,560,000 shares $4.31 million -7.1%4.5%4.7 $2.76
9/15/20221,680,000 shares $6.89 million -6.2%4.9%4.2 $4.10
8/31/20221,790,000 shares $7.07 million -6.3%5.2%4 $3.95
8/15/20221,910,000 shares $8.16 million +6.1%5.6%3.7 $4.27
7/31/20221,800,000 shares $9.04 million +0.6%5.2%3.4 $5.02
7/15/20221,790,000 shares $8.41 million -14.8%5.2%3.3 $4.70
6/30/20222,100,000 shares $8.55 million -23.6%6.1%4.6 $4.07
6/15/20222,750,000 shares $10.20 million +10.9%8.1%6 $3.71













OLMA Short Interest - Frequently Asked Questions

What is Olema Pharmaceuticals' current short interest?

Short interest is the volume of Olema Pharmaceuticals shares that have been sold short but have not yet been closed out or covered. As of January 31st, investors have sold 6,710,000 shares of OLMA short. Learn More on Olema Pharmaceuticals' current short interest.

What is a good short interest ratio for Olema Pharmaceuticals?

The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. OLMA shares currently have a short interest ratio of 8.0. Learn More on Olema Pharmaceuticals's short interest ratio.

Which institutional investors are shorting Olema Pharmaceuticals?

As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of Olema Pharmaceuticals: Citadel Advisors LLC, Concourse Financial Group Securities Inc., and Simplex Trading LLC. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission.

Is Olema Pharmaceuticals' short interest increasing or decreasing?

Olema Pharmaceuticals saw a drop in short interest in the month of January. As of January 31st, there was short interest totaling 6,710,000 shares, a drop of 5.2% from the previous total of 7,080,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

How does Olema Pharmaceuticals' short interest compare to its competitors?

Here is how the short interest of companies in the industry of "pharmaceutical preparations" compare to Olema Pharmaceuticals: RAPT Therapeutics, Inc. (11.48%), 89bio, Inc. (10.33%), Tyra Biosciences, Inc. (10.81%), IGM Biosciences, Inc. (22.49%), Pliant Therapeutics, Inc. (10.37%), MannKind Co. (12.98%), Assembly Biosciences, Inc. (6.45%), Centessa Pharmaceuticals plc (1.90%), Verve Therapeutics, Inc. (21.94%), Liquidia Co. (8.88%),

Which stocks are the most shorted right now?

As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($4.48 billion), General Motors ($3.85 billion), Charter Communications, Inc. ($3.38 billion), Occidental Petroleum Co. ($3.00 billion), Super Micro Computer, Inc. ($2.66 billion), Tractor Supply ($2.37 billion), Coinbase Global, Inc. ($2.25 billion), Moderna, Inc. ($2.11 billion), Royal Caribbean Cruises Ltd. ($2.06 billion), and Floor & Decor Holdings, Inc. ($1.67 billion). View all of the most shorted stocks.

What does it mean to sell short Olema Pharmaceuticals stock?

Short selling OLMA is an investing strategy that aims to generate trading profit from Olema Pharmaceuticals as its price is falling. OLMA shares are trading down $0.65 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

How does a short squeeze work against Olema Pharmaceuticals?

A short squeeze for Olema Pharmaceuticals occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of OLMA, which in turn drives the price of the stock up even further.

How often is Olema Pharmaceuticals' short interest reported?

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including OLMA, twice per month. The most recent reporting period available is January, 31 2024.



More Short Interest Resources from MarketBeat

This page (NASDAQ:OLMA) was last updated on 2/21/2024 by MarketBeat.com Staff